Last reviewed · How we verify
NCT06132074
Adolescent Consent & Sexual Violence: A School Intervention Evaluation
NA trial testing School sessions on consent, reciprocity and sexual violence in Violence Prevention Intervention Evaluation Among Youth in 600 participants. Status unknown.
30 May 2024
Quick facts
| Lead sponsor | Uppsala University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 600 |
| Start date | 11 October 2023 |
| Primary completion | 30 May 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- School sessions on consent, reciprocity and sexual violence
Conditions studied
- Violence Prevention Intervention Evaluation Among Youth — all drugs for Violence Prevention Intervention Evaluation Among Youth →
Sponsor
Uppsala University
Who can join
Adults 15 to 18, any sex, with Violence Prevention Intervention Evaluation Among Youth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Since 2015, Uppsala Tjej- och Transjour has run school sessions for secondary school pupils in Uppsala municipality, from year 9 to year 2. The school session is a 120-minute workshop and focuses on increasing knowledge and changing attitudes about consent, reciprocity and sexual violence. The intervention aims to increase participants' knowledge about consent, reciprocity, sex, sexuality and sexual violence in order to create positive attitudinal changes around gender and sexual violence and influence behaviour. The purpose of the study is to evaluate the effect of Uppsala Tjej- och Transjour's school intervention on young people's knowledge, attitudes and behaviour regarding consent, reciprocity and sexual violence. A cluster randomised controlled trial with 16 clusters (89 participants in each cluster) in each arm, a total of 32 clusters. Schools are randomised after baseline measurement to receive the intervention in autumn 2023 or spring 2024 (waiting list). Data collection is done through a questionnaire at two measurement points. A baseline measurement before the intervention (T1) and measurement two (T2) 6 months later. There are still few violence prevention programmes in Sweden that have been evaluated for effectiveness, and several programmes come from the USA. This study is based on a Swedish material and constitutes an important contribution to the development of more effective methods for violence prevention and increased insights into reciprocity and consent.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06132074
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Uppsala University trials
Trials by the same sponsor.
- NCT07517185 — The HIt HArd and hiT Early in Multiple Sclerosis Trial · Phase 2 · not yet recruiting
- NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
- NCT07461636 — Robotic-Assisted Pedicle Screw Placement in Spine Surgery · recruiting
- NCT07273409 — Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · NA · recruiting
- NCT07352683 — Open TAP-block in Pediatric Abdominal Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06132074 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uppsala University
- Last refreshed: 30 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06132074.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing